|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Exelixis, Inc. (EXEL) Announces June 6th Webcast of Presentation at the Goldman, Sachs & Co. 33rd Annual Global Healthcare Conference
6/1/2012 9:56:44 AM
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) announced today that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at the Goldman Sachs 33rd Annual Global Healthcare Conference at 12:20 p.m. EDT / 9:20 a.m. PDT on Wednesday, June 6, 2012, in Rancho Palos Verdes, California. During the presentation, Dr. Morrissey will discuss the company’s development program and plans for cabozantinib, and review the most recent publicly available data for the compound, including data presented at the 2012 ASCO Annual Meeting. He will also provide a general business update.
|
|
|
|
|
|
|
|
|
|
|